OL
NUVB icon

Odyssean LLC’s Nuvation Bio NUVB Stock Holding History

Odyssean LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$954K Buy
168,009
+104,912
+166% +$513K 0.16% 218
2026
Q1 		$271K Buy
63,097
+35,594
+129% +$198K 0.1% 316
2025
Q4 		$246K Buy
+27,503
New +$170K 0.18% 204

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Odyssean LLC's NUVB Position: Q2 2026 in Review

Odyssean LLC increased its Nuvation Bio (NUVB) stake by 166% in Q2 2026, buying an estimated $513K and bringing the position to 168,009 shares worth $954K. The position accounts for 0.16% of the portfolio, ranked #218.

Odyssean LLC first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Odyssean LLC held 168,009 shares of Nuvation Bio worth $954K as of Q2 2026.
  • Odyssean LLC bought 104,912 Nuvation Bio shares in Q2 2026, an estimated $513K.
  • Nuvation Bio made up 0.16% of Odyssean LLC's portfolio in Q2 2026, its #218 holding.
  • Odyssean LLC first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.